Stock Price
3.02
Daily Change
0.05 1.68%
Monthly
-3.21%
Yearly
106.85%
Q1 Forecast
2.88

Galectin Therapeutics reported $3.7M in Trade Creditors for its fiscal quarter ending in June of 2024.





Trade Creditors Change Date
AbbVie USD 3.59B 28.65B Dec/2025
Bristol-Myers Squibb USD 4.29B 1.14B Sep/2025
Galectin Therapeutics USD 3.7M 99K Jun/2024
Gilead Sciences USD 808M 226M Sep/2025
Immunic USD 7.92M 25K Sep/2025
Incyte USD 1.63B 1.46B Dec/2025
Merck USD 4.15B 102M Sep/2025